Human Reproduction, Vol. 16, No. 12, 2606-2609,
December 2001
© 2001 European Society of Human Reproduction and Embryology
Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment
Reproductive Medicine Unit, Department of Obstetrics and Gynaecology, University of Adelaide, The Queen Elizabeth Hospital, Woodville, SA 5011, Australia
BACKGROUND: A high proportion of infertile patients have polycystic ovarian syndrome (PCOS) with a reportedly greater risk of spontaneous abortion. Because of the close link between PCOS and obesity and the independent association of obesity with poor pregnancy outcomes, it is important to distinguish the possible confounding effect of body mass index (BMI) or other variables from that of PCOS. This study aims to determine the effect of PCOS status on the risk of spontaneous abortion with adjustment for body mass and several other confounding factors in a large cohort of pregnant infertile women. METHODS: The patients (n = 1018) were treated in a tertiary infertility centre. Their PCOS status was determined by standard criteria and their BMI had been taken less than 1 year before the pregnancy. Patients whose PCOS status or BMI measurements were not assessed were excluded. Student's t-test or 
2 test were used to test the difference between the PCOS and non-PCOS groups while a multivariate logistical regression model was used to assess the effect of PCOS, BMI and other confounding factors. RESULTS: Overall, the incidence of PCOS was 37% in this cohort. The overall incidence of spontaneous abortion in the study population was 21%. Univariate analysis showed that women with PCOS had a significantly greater risk of spontaneous abortion compared with non-PCOS women (25 versus 18%, P < 0.01). However, using multivariate logistic regression analysis this effect was reduced to a non-significant level [odds ratio (OR) = 1.10, 95% confidence interval (CI) 0.85–1.36] after adjusting for obesity and patients/treatment combination factor, and to nil after adjusting for all confounding factors considered in this study (OR = 0.98, 95% CI 0.75–1.28). CONCLUSION: The results of this study suggest that the higher risk of spontaneous abortion observed in women with PCOS is likely to be due to their high prevalence of obesity and the type of treatment they receive.
Key words: BMI/PCOS/spontaneous abortion
1 To whom correspondence should be addressed. E-mail: jim.wang{at}adelaide.edu.au
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Hudecova, J. Holte, M. Olovsson, and I. Sundstrom Poromaa Long-term follow-up of patients with polycystic ovary syndrome: reproductive outcome and ovarian reserve Hum. Reprod., May 1, 2009; 24(5): 1176 - 1183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.A. Cocksedge, S.H. Saravelos, Q. Wang, E. Tuckerman, S.M. Laird, and T.C. Li Does free androgen index predict subsequent pregnancy outcome in women with recurrent miscarriage? Hum. Reprod., April 1, 2008; 23(4): 797 - 802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Veleva, A. Tiitinen, S. Vilska, C. Hyden-Granskog, C. Tomas, H. Martikainen, and J. S. Tapanainen High and low BMI increase the risk of miscarriage after IVF/ICSI and FET Hum. Reprod., April 1, 2008; 23(4): 878 - 884. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Tian, H. Shen, Q. Lu, R. J. Norman, and J. Wang Insulin Resistance Increases the Risk of Spontaneous Abortion after Assisted Reproduction Technology Treatment J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1430 - 1433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 The ESHRE Capri Workshop Group Nutrition and reproduction in women Hum. Reprod. Update, May 1, 2006; 12(3): 193 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. T. Bloomgarden Second World Congress on the Insulin Resistance Syndrome: Mediators, pediatric insulin resistance, the polycystic ovary syndrome, and malignancy Diabetes Care, July 1, 2005; 28(7): 1821 - 1830. [Full Text] [PDF]
|
|
|
|
|
|
M.A. Checa, A. Requena, C. Salvador, R. Tur, J. Callejo, J.J. Espinos, F. Fabregues, J. Herrero, and (Reproductive Endocrinology Interest Group of the Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome Hum. Reprod. Update, July 1, 2005; 11(4): 375 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Fedorcsak, P. O. Dale, R. Storeng, G. Ertzeid, S. Bjercke, N. Oldereid, A. K. Omland, T. Abyholm, and T. Tanbo Impact of overweight and underweight on assisted reproduction treatment Hum. Reprod., November 1, 2004; 19(11): 2523 - 2528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Lashen, K. Fear, and D.W. Sturdee Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study Hum. Reprod., July 1, 2004; 19(7): 1644 - 1646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.J. Glueck, N. Goldenberg, J. Pranikoff, M. Loftspring, L. Sieve, and P. Wang Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy Hum. Reprod., June 1, 2004; 19(6): 1323 - 1330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. De Leo, A. la Marca, and F. Petraglia Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome Endocr. Rev., October 1, 2003; 24(5): 633 - 667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Glueck, P. Wang, N. Goldenberg, and L. Sieve-Smith Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin Hum. Reprod., November 1, 2002; 17(11): 2858 - 2864. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D J Cahill and P G Wardle Management of infertility BMJ, July 6, 2002; 325(7354): 28 - 32. [Full Text] [PDF]
|
|